Dr. Jaspal Singh MD

Recommended Articles

• ‘Screaming for Help' Over Orkambi Drug for Cystic Fibrosis

  When a person has a debilitating disease, dealing with that reality is enough to bear.But, when there is a drug out there to limit the debilitation of that disease, and governmental decision-makers don’t provide patients with it, the fight about injustice becomes overbearing.The denial for your...

• Antibiotics May Not Alleviate the Symptoms of Sinusitis

  A recent study has shown that antibiotics like amoxicillin are not very effective in controlling the symptoms of sinusitis, which is the infection of sinuses and the nasal passages. The study was conducted on 166 participants and the results are published in the journal of the American Medical...

• What is Acute Bronchitis?

  What is Bronchitis?We often run under weather catching a flu or a cold that stays on for a couple of days to weeks, after which we normally get back to normal. However, sometimes even a small infection of cold or flu, could turn into a bronchitis infection causing much disturbance to your normal...

• What are the Early Signs of Lupus?

  Systemic lupus erythematosus (also known as lupus) is a condition that usually affects women. It occurs as a result of antibodies or lymphocytes generated against substances that exist in the body. Approximately one out of 2,100 people has the condition.Women are five times more vulnerable to...

• Pulmonary Rehabilitation for Patients with COPD

  Patients who are diagnosed with chronic obstructive pulmonary disease (COPD) should expect mucus production that is tenacious, long-term coughing, and extreme fatigue. The main concern with COPD is if permanent scars have developed in the lungs. If scarring does occur, the condition cannot be cured...

• New Cystic Fibrosis Treatment Shows Promise for those with a Specific Gene Mutation

  The data released on July 18th from three clinical trials conducted by Vertex Pharmaceuticals revealed promising results. The drugs that were tested in these trials are three different triple combination regimes that are designed to treat the underlying cause of cystic fibrosis in patients with the...